We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current CERE market cap is 7.73B. The company's latest EPS is USD -2.3838 and P/E is -4.24.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -95.07M | -107.25M | -99.55M | -96.84M | -111.31M |
| Net Income | -99.94M | -92.81M | -104.29M | -99.54M | -96.36M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -149.12M | -220.1M | -367.85M | -447.27M |
| Net Income | -148.27M | -225.33M | -351.51M | -432.84M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 1.09B | 1.02B | 930.35M | 894.35M | 821.96M |
| Total Liabilities | 490.35M | 496.58M | 498.64M | 543.85M | 549M |
| Total Equity | 603.36M | 521.24M | 431.71M | 350.5M | 272.96M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 445.27M | 688.92M | 1.02B | 1.24B |
| Total Liabilities | 60.75M | 110.19M | 496.58M | 569.55M |
| Total Equity | 384.52M | 578.73M | 521.24M | 673.75M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -205.71M | -293.19M | -94.92M | -172.25M | -244.88M |
| Investing | -362.1M | -388.83M | 110.78M | 172.54M | 223.93M |
| Financing | 621.06M | 623.19M | 1.44M | 39.05M | 40.24M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -121.33M | -181.55M | -293.19M | -342.3M |
| Investing | -18.89M | -435.66M | -388.83M | 73.72M |
| Financing | 440.84M | 423.6M | 623.19M | 548.62M |
| Market Cap | 7.73B |
| Price to Earnings Ratio | -4.24 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.4 |
| Price to Book Ratio | 2.72 |
| Dividend Yield | - |
| Shares Outstanding | 181.58M |
| Average Volume (1 week) | 1.02M |
| Average Volume (1 Month) | 1.07M |
| 52 Week Change | 47.49% |
| 52 Week High | 43.5898 |
| 52 Week Low | 19.59 |
| Spread (Intraday) | 0.26 (0.61%) |
| Company Name | Cerevel Therapeutics Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.cerevel.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
